4.7 Article

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Surgical Treatments of Hepatobiliary Cancers

Ganesh Gunasekaran et al.

Summary: Hepatobiliary cancers, including HCC and biliary tract cancers, have significant morbidity and mortality rates. Treatment options vary based on disease stage, with surgical resection offering potential cure for early-stage disease, while ablation and liver transplantation can be considered for inoperable cases. Multi-disciplinary evaluation is essential for optimal management of these cancers.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity

Stefano Caruso et al.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Improving the Efficacy of Liver Cancer Immunotherapy: The Power of Combined Preclinical and Clinical Studies

Gen-Sheng Feng et al.

Summary: Hepatocellular carcinoma is a deadly malignant disease with limited effectiveness of immune checkpoint inhibitors, requiring further research and clinical practice to improve immunotherapy outcomes.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Liver Cancer Immunity

Sumera Rizvi et al.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

The Tumor Microenvironment in Cholangiocarcinoma Progression

Luca Fabris et al.

HEPATOLOGY (2021)

Review Biochemical Research Methods

A review of digital cytometry methods: estimating the relative abundance of cell types in a bulk of cells

Trang Le et al.

Summary: Due to the high cost of flow and mass cytometry, computational methods have been developed for estimating cell type distributions from gene expression profiles. Among the methods reviewed, CIBERSORTx B-mode performs best by adjusting for batch effects in mixture data. However, CIBERSORTx S-mode did not outperform the original CIBERSORT method without batch correction, indicating the need for further research on batch correction in deconvolution methods.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Multidisciplinary Sciences

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma

Hsiang-chi Tseng et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update

Christo Kole et al.

CANCERS (2020)

Review Immunology

Immune surveillance of the liver by T cells

Xenia Ficht et al.

SCIENCE IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Immunotherapy for advanced hepatocellular carcinoma, where are we?

Li Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Review Gastroenterology & Hepatology

Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy

Zachary J. Brown et al.

HEPATOLOGY (2019)

Review Biochemistry & Molecular Biology

Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma

Jian Chen et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

Diego Chowell et al.

NATURE MEDICINE (2019)

Article Gastroenterology & Hepatology

Epidemiology and Management of Hepatocellular Carcinoma

Laura Kulik et al.

GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Treatment strategies for locally advanced hepatocellular carcinoma

Eduardo De Souza Martins Fernandes et al.

TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Oncology

Immune checkpoint therapy in liver cancer

Feng Xu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

ImmPort, toward repurposing of open access immunological assay data for translational and clinical research

Sanchita Bhattacharya et al.

SCIENTIFIC DATA (2018)

Review Pharmacology & Pharmacy

Regorafenib: a promising treatment for hepatocellular carcinoma

Lucia Cerrito et al.

EXPERT OPINION ON PHARMACOTHERAPY (2018)

Article Oncology

Classification of triple-negative breast cancers based on Immunogenomic profiling

Yin He et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Review Biochemistry & Molecular Biology

The biology of Hepatocellular carcinoma: implications for genomic and immune therapies

Galina Khemlina et al.

MOLECULAR CANCER (2017)

Article Biochemistry & Molecular Biology

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally et al.

Article Biochemistry & Molecular Biology

A Landscape of Pharmacogenomic Interactions in Cancer

Francesco Iorio et al.

Review Gastroenterology & Hepatology

Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

Jordi Bruix et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis

Laurence Amiot et al.

JOURNAL OF HEPATOLOGY (2014)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Biotechnology & Applied Microbiology

Differential expression analysis for sequence count data

Simon Anders et al.

GENOME BIOLOGY (2010)

Review Gastroenterology & Hepatology

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

Rashmi Singh et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)